Johnson Investment Counsel’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.66M | Buy |
7,360
+17
| +0.2% | +$7.53K | 0.03% | 224 |
|
|
2026
Q1 | $3.28M | Sell |
7,343
-383
| -5% | -$179K | 0.03% | 224 |
|
|
2025
Q4 | $3.5M | Sell |
7,726
-4
| -0.1% | -$1.72K | 0.03% | 202 |
|
|
2025
Q3 | $3.03M | Sell |
7,730
-18
| -0.2% | -$7.52K | 0.03% | 233 |
|
|
2025
Q2 | $3.45M | Sell |
7,748
-171
| -2% | -$78.8K | 0.03% | 207 |
|
|
2025
Q1 | $3.84M | Buy |
7,919
+36
| +0.5% | +$16.8K | 0.04% | 196 |
|
|
2024
Q4 | $3.17M | Buy |
7,883
+63
| +0.8% | +$29.2K | 0.03% | 208 |
|
|
2024
Q3 | $3.64M | Sell |
7,820
-61
| -0.8% | -$29.3K | 0.04% | 196 |
|
|
2024
Q2 | $3.69M | Buy |
7,881
+8
| +0.1% | +$3.47K | 0.04% | 182 |
|
|
2024
Q1 | $3.29M | Sell |
7,873
-1,566
| -17% | -$662K | 0.04% | 200 |
|
|
2023
Q4 | $3.84M | Buy |
9,439
+1,051
| +13% | +$388K | 0.05% | 172 |
|
|
2023
Q3 | $2.92M | Buy |
8,388
+8
| +0.1% | +$2.8K | 0.04% | 196 |
|
|
2023
Q2 | $2.95M | Sell |
8,380
-156
| -2% | -$52.6K | 0.04% | 188 |
|
|
2023
Q1 | $2.69M | Sell |
8,536
-233
| -3% | -$69.9K | 0.04% | 197 |
|
|
2022
Q4 | $2.53M | Sell |
8,769
-471
| -5% | -$144K | 0.03% | 204 |
|
|
2022
Q3 | $2.67M | Sell |
9,240
-568
| -6% | -$163K | 0.04% | 185 |
|
|
2022
Q2 | $2.76M | Sell |
9,808
-241
| -2% | -$64.5K | 0.04% | 181 |
|
|
2022
Q1 | $2.62M | Buy |
10,049
+1,594
| +19% | +$378K | 0.03% | 201 |
|
|
2021
Q4 | $1.86M | Sell |
8,455
-508
| -6% | -$98.8K | 0.02% | 255 |
|
|
2021
Q3 | $1.63M | Sell |
8,963
-159
| -2% | -$31K | 0.02% | 262 |
|
|
2021
Q2 | $1.84M | Buy |
9,122
+73
| +0.8% | +$15.3K | 0.03% | 232 |
|
|
2021
Q1 | $1.95M | Sell |
9,049
-13
| -0.1% | -$2.85K | 0.03% | 218 |
|
|
2020
Q4 | $2.14M | Buy |
9,062
+64
| +0.7% | +$14.7K | 0.04% | 185 |
|
|
2020
Q3 | $2.45M | Buy |
8,998
+6
| +0.1% | +$1.66K | 0.05% | 168 |
|
|
2020
Q2 | $2.61M | Sell |
8,992
-355
| -4% | -$96.2K | 0.05% | 162 |
|
|
2020
Q1 | $2.22M | Sell |
9,347
-63
| -0.7% | -$14.5K | 0.05% | 161 |
|
|
2019
Q4 | $2.06M | Sell |
9,410
-366
| -4% | -$74.1K | 0.04% | 197 |
|
|
2019
Q3 | $1.66M | Sell |
9,776
-338
| -3% | -$59.8K | 0.03% | 214 |
|
|
2019
Q2 | $1.85M | Buy |
10,114
+242
| +2% | +$42.3K | 0.04% | 205 |
|
|
2019
Q1 | $1.81M | Sell |
9,872
-160
| -2% | -$29.6K | 0.04% | 215 |
|
|
2018
Q4 | $1.66M | Sell |
10,032
-114
| -1% | -$19.8K | 0.04% | 217 |
|
|
2018
Q3 | $1.96M | Sell |
10,146
-150
| -1% | -$26.7K | 0.04% | 214 |
|
|
2018
Q2 | $1.75M | Sell |
10,296
-16
| -0.2% | -$2.48K | 0.04% | 206 |
|
|
2018
Q1 | $1.68M | Buy |
10,312
+45
| +0.4% | +$7.35K | 0.04% | 193 |
|
|
2017
Q4 | $1.54M | Sell |
10,267
-171
| -2% | -$25.3K | 0.04% | 208 |
|
|
2017
Q3 | $1.59M | Sell |
10,438
-3,023
| -22% | -$455K | 0.04% | 196 |
|
|
2017
Q2 | $1.73M | Sell |
13,461
-1,712
| -11% | -$206K | 0.05% | 181 |
|
|
2017
Q1 | $1.66M | Sell |
15,173
-4,657
| -23% | -$410K | 0.05% | 176 |
|
|
2016
Q4 | $1.46M | Sell |
19,830
-6,207
| -24% | -$505K | 0.04% | 184 |
|
|
2016
Q3 | $2.27M | Sell |
26,037
-2,877
| -10% | -$272K | 0.07% | 156 |
|
|
2016
Q2 | $2.49M | Sell |
28,914
-3,090
| -10% | -$267K | 0.08% | 151 |
|
|
2016
Q1 | $2.54M | Sell |
32,004
-865
| -3% | -$78.2K | 0.09% | 143 |
|
|
2015
Q4 | $4.13M | Sell |
32,869
-2,421
| -7% | -$292K | 0.15% | 113 |
|
|
2015
Q3 | $3.67M | Sell |
35,290
-89,027
| -72% | -$11.4M | 0.13% | 117 |
|
|
2015
Q2 | $15.3M | Sell |
124,317
-48,105
| -28% | -$6.06M | 0.52% | 55 |
|
|
2015
Q1 | $20.3M | Sell |
172,422
-10,201
| -6% | -$1.22M | 0.68% | 44 |
|
|
2014
Q4 | $21.7M | Sell |
182,623
-25,660
| -12% | -$2.89M | 0.71% | 47 |
|
|
2014
Q3 | $23.4M | Buy |
208,283
+40
| +0% | +$3.81K | 0.78% | 46 |
|
|
2014
Q2 | $19.7M | Buy |
208,243
+200,713
| +2,666% | +$14.1M | 0.7% | 43 |
|
|
2014
Q1 | $532K | Sell |
7,530
-400
| -5% | -$31.7K | 0.02% | 266 |
|
|
2013
Q4 | $589K | Sell |
7,930
-570
| -7% | -$39.7K | 0.02% | 251 |
|
|
2013
Q3 | $644K | Sell |
8,500
-3,435
| -29% | -$273K | 0.03% | 226 |
|
|
2013
Q2 | $955K | Buy |
+11,935
| New | +$879K | 0.04% | 176 |
|
Other funds holding VRTX
Johnson Investment Counsel's VRTX Position: Q2 2026 in Review
Johnson Investment Counsel increased its Vertex Pharmaceuticals (VRTX) stake by 0.23% in Q2 2026, buying an estimated $7.53K and bringing the position to 7,360 shares worth $3.66M. The position accounts for 0.03% of the portfolio, ranked #224.
Johnson Investment Counsel first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $23.4M in Q3 2014. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Johnson Investment Counsel held 7,360 shares of Vertex Pharmaceuticals worth $3.66M as of Q2 2026.
- Johnson Investment Counsel bought 17 Vertex Pharmaceuticals shares in Q2 2026, an estimated $7.53K.
- Vertex Pharmaceuticals made up 0.03% of Johnson Investment Counsel's portfolio in Q2 2026, its #224 holding.
- Johnson Investment Counsel first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Johnson Investment Counsel's Vertex Pharmaceuticals position peaked at $23.4M in Q3 2014.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.